299 related articles for article (PubMed ID: 33733904)
1. Performance Characteristics of DOAC Dipstick in Determining Direct Oral Anticoagulants in Urine.
Harenberg J; Martini A; Du S; Krämer S; Weiss C; Hetjens S
Clin Appl Thromb Hemost; 2021; 27():1076029621993550. PubMed ID: 33733904
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants.
Papageorgiou L; Hetjens S; Fareed J; Auge S; Tredler L; Harenberg J; Weiss C; Elalamy I; Gerotziafas GT
Clin Appl Thromb Hemost; 2023; 29():10760296231179684. PubMed ID: 37278029
[TBL] [Abstract][Full Text] [Related]
3. Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy Study.
Merrelaar AE; Bögl MS; Buchtele N; Merrelaar M; Herkner H; Schoergenhofer C; Harenberg J; Douxfils J; Siriez R; Jilma B; Spiel AO; Schwameis M
Thromb Haemost; 2022 Oct; 122(10):1723-1731. PubMed ID: 35785816
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter Trial.
Harenberg J; Beyer-Westendorf J; Crowther M; Douxfils J; Elalamy I; Verhamme P; Bauersachs R; Hetjens S; Weiss C;
Thromb Haemost; 2020 Jan; 120(1):132-140. PubMed ID: 31705521
[TBL] [Abstract][Full Text] [Related]
5. DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation.
Margetić S; Ćelap I; Huzjan AL; Puretić MB; Goreta SŠ; Glojnarić AČ; Brkljačić DD; Mioč P; Harenberg J; Hetjens S; Weiss C
Thromb Haemost; 2022 Sep; 122(9):1542-1548. PubMed ID: 35088395
[TBL] [Abstract][Full Text] [Related]
6. Patients' Plasma Activity of Heparin, low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips.
Harenberg J; Hetjens S; Weiss C
Clin Appl Thromb Hemost; 2022; 28():10760296221083667. PubMed ID: 35275493
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration.
Örd L; Marandi T; Märk M; Raidjuk L; Kostjuk J; Banys V; Krause K; Pikta M
Clin Appl Thromb Hemost; 2022; 28():10760296221084307. PubMed ID: 35249379
[TBL] [Abstract][Full Text] [Related]
8. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the Residual Activity of Dabigatran, Rivaroxaban, and Apixaban.
Slavik L; Jacova J; Friedecky D; Ulehlova J; Tauber Z; Prochazkova J; Hlusi A; Palova M
Clin Appl Thromb Hemost; 2019; 25():1076029619872556. PubMed ID: 31523979
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
Gosselin R; Grant RP; Adcock DM
Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
[TBL] [Abstract][Full Text] [Related]
11. Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick.
Harenberg J; Schreiner R; Hetjens S; Weiss C
Semin Thromb Hemost; 2019 Apr; 45(3):275-284. PubMed ID: 30134449
[TBL] [Abstract][Full Text] [Related]
12. Challenges to Laboratory Monitoring of Direct Oral Anticoagulants.
Qiao J; Tran MH
Clin Appl Thromb Hemost; 2024; 30():10760296241241524. PubMed ID: 38650302
[TBL] [Abstract][Full Text] [Related]
13. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
Ząbczyk M; Kopytek M; Natorska J; Undas A
Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
[TBL] [Abstract][Full Text] [Related]
14. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis.
Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Rupp A; Blumenstock G; Zuern CS; Ziemann U; Poli S
J Am Heart Assoc; 2018 Oct; 7(19):e009807. PubMed ID: 30371316
[TBL] [Abstract][Full Text] [Related]
15. Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs - A Systematic Review and Meta-analysis.
Martini A; Harenberg J; Bauersachs R; Beyer-Westendorf J; Crowther M; Douxfils J; Elalamy I; Weiss C; Hetjens S
TH Open; 2021 Jul; 5(3):e438-e448. PubMed ID: 34595388
[TBL] [Abstract][Full Text] [Related]
16. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.
Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
Stroke; 2017 Sep; 48(9):2457-2463. PubMed ID: 28775134
[TBL] [Abstract][Full Text] [Related]
17. New oral anticoagulants: comparative pharmacology with vitamin K antagonists.
Scaglione F
Clin Pharmacokinet; 2013 Feb; 52(2):69-82. PubMed ID: 23292752
[TBL] [Abstract][Full Text] [Related]
18. Measurement and reversal of the direct oral anticoagulants.
Samuelson BT; Cuker A
Blood Rev; 2017 Jan; 31(1):77-84. PubMed ID: 27625113
[TBL] [Abstract][Full Text] [Related]
19. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509
[TBL] [Abstract][Full Text] [Related]
20. Development of a Rapid Qualitative Screen for Anticoagulant Presence.
Wong S; Slingerland J; Dickerson JA; Pak J; Roach GD; Saifee NH
J Appl Lab Med; 2024 Mar; 9(2):305-315. PubMed ID: 38101950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
